I wanted to take a moment to thank each and every member of the Clinipace Worldwide team for playing a vital role in our continued success and national recognition.
Clinipace was recently named to FORBES’ Most Promising Companies list, ranking #36 in a prestigious group of 100 privately held, high-growth US companies. This list is based on sales and company growth, quality of management team and investors, margins, market size and key partnerships.
This award comes on the heels of other accolades, including being named to Inc. Magazine’s Inc. 500 list for the third consecutive year in August 2012. The Inc. 500 is a compilation of the fastest growing, privately held companies in the country, recognizing their success and potential for the future. Clinipace ranked 260th overall and 22nd among Inc.’s Top Health Companies based on 1383% growth over the past three years.
Having co-founded Clinipace Worldwide in 2003 with Chris Porter and Ron Marks, we began with the idea of building a clinical research company that takes a different approach to managing clinical trials, where technology serves as the foundation of research. Almost ten years into our endeavor, it is a real honor to be so well received in the greater business community and is a true testament to the hard work and dedication that each employee has put into this company.
With the vision of being the leader in deploying technology-amplified services to emerging, venture-backed, mid-tier and strategic biopharmaceutical and medical device firms, our core values help drive profitability and sustainability for the benefit of our employees, clients, and shareholders.
We are honored these awards not only recognize our success thus far, but also recognize our growth potential for the future. Moving forward, we will continue building our global capacity and delivering innovative research services and technology to support growth within our industry. These awards serve to bolster our commitment to our vision and core values. It’s a great time to be a part of Clinipace Worldwide, the clinical research industry, and the larger business community!